New drug Baochang (polycarboside calcium tablets) of Xinhua Pharmaceutical Group 3.1 will be on the market soon
-
Last Update: 2014-06-22
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Baochang (polycarbonate non calcium tablets) is used to improve the gastrointestinal symptoms such as constipation, diarrhea, abdominal pain and abdominal distention in IBS, and also can be used for constipation symptoms caused by other reasons The incidence rate of irritable bowel syndrome is about 10% - 22%, and the incidence rate of chronic constipation is about 15% All these are common and frequently occurring diseases, which seriously affect the daily life of patients Constipation makes the body unable to eliminate the toxicant in time, wastes and harmful substances are easy to be re absorbed by the body, especially the carcinogens contained in them accumulate in the intestine for a long time, which is easy to cause rectal cancer and other digestive system cancers; Diarrhea will reduce the body's resistance, lead to malnutrition, anemia and vitamin deficiency, and weaken the body's resistance to infectious diseases and various infections It can be seen that irritable bowel syndrome and chronic constipation are very harmful At present, the drugs used to treat irritable bowel syndrome and chronic constipation generally have certain limitations, such as certain irritation, drug dependence, electrolyte disorder, various symptoms can not be considered, which can cause watery stool and low blood potassium, the effective rate is not high, long-term application can lead to colon melanosis and increase the risk of colorectal cancer Bao Chang's listing will be effective in improving the current situation: calcium in capsabis calcium can become free in the acidic condition of the stomach, and it is not absorbed by human body, but it can be used to treat gastrointestinal diseases such as diarrhoea, constipation, abdominal pain and abdominal distension by using the characteristics of swelling and gelation under the neutral conditions of the small intestine and large intestine It can induce intestinal movement 12-72 hours after taking this product It can improve many symptoms of irritable bowel syndrome It has the following characteristics: first, it has high efficiency and can double regulate the symptoms of constipation and diarrhea; second, it has high safety, no absorption, no stimulation, no dependence and no electrolyte disorder; third, it has high quality The raw materials of Xinhua Pharmaceutical have passed the quality audit in many countries Shandong Xinhua Pharmaceutical Co., Ltd is the first manufacturer of polycarboside bulk drug with the largest scale and the highest technical level in China In 2005, it achieved large-scale production with a production capacity of 500 tons / year, exported to the United States, Japan and other markets Through multi country quality audit, the internal control standard is higher than USP, ensuring the excellent quality of polycarboside calcium tablets Baochang (polycarbonate non calcium tablets) to be launched on the market is divided into two packaging specifications, one is 0.5g × 20 tablets, the other is 0.5g × 30 tablets The successful listing of Baochang (polycarbonate non calcium tablets) marks the breakthrough of Shandong Xinhua Pharmaceutical Co., Ltd in the field of new drug research and development The product will become another heavy bomb in the chemical elimination system of Shandong Xinhua Pharmaceutical Co., Ltd after the preparation relay shuted (rabeprazole sodium enteric coated tablets), and is expected to become the leader of Shandong Xinhua Pharmaceutical Co., Ltd in its large-scale preparation strategy Varieties.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.